Iloprost for lung disease with high blood pressure in lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests if inhaling a drug called iloprost can help patients who have both severe COPD and high blood pressure in the lungs (pulmonary hypertension). It may improve blood flow and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older
- You have severe or very severe COPD (GOLD stage 3 or 4)
- You have pulmonary hypertension confirmed by a heart catheterization test, with specific pressure and resistance levels
- You are not allergic to iloprost or similar drugs
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial is for adults with pulmonary hypertension who are on the lung transplant waiting list at Duke. It aims to test whether the study treatment can improve lung pressure and related health outcomes, while using things like MRI to monitor changes.
This study tests a medicine called prostacyclin (given through a vein) to see if it helps people on a breathing machine with a lung infection. The goal is to reduce inflammation and improve recovery.
This trial tests an inhaled medicine (TPIP) for people with both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug helps improve exercise ability and symptoms.
This trial tests whether an inhaled medication called treprostinil can improve exercise ability in people with exercise-induced pulmonary hypertension. It aims to see if the drug helps with shortness of breath during activity.
This trial tests if iloprost, a medicine that helps open blood vessels, can reduce pain from a sickle cell crisis. It's for adults with sickle cell disease who need to be in the hospital for strong pain medicine.
This trial tests if treprostinil can help people with pulmonary arterial hypertension (PAH) who are at intermediate risk. You may join if you have been diagnosed with certain types of PAH and meet specific heart and lung test results.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.